Insiders · PHGE

PHGE insider transactions

BiomX Inc. (PHGE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PHGE

• 82d
  SEC Form 4 filed by Yeganeh Reuven

  4 - BiomX Inc. (0001739174) (Issuer)
• 87d
  Director Yeganeh Reuven sold $3,350,000 worth of shares (670,000 units at $5.00) and converted options into 670,000 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 97d
  SEC Form 3 filed by new insider Bidas Liat Cohavi

  3 - BiomX Inc. (0001739174) (Issuer)
• 143d
  SEC Form 3 filed by new insider Yeganeh Reuven

  3 - BiomX Inc. (0001739174) (Issuer)
• 411d
  SEC Form 4 filed by *Director by Deputization Flynn James E

  4 - BiomX Inc. (0001739174) (Issuer)
• 413d
  Amendment: SEC Form 4 filed by Director Merril Gregory Louis

  4/A - BiomX Inc. (0001739174) (Issuer)
• 413d
  Amendment: Chief Development Officer Bassan Merav was granted 79,597 shares (SEC Form 4)

  4/A - BiomX Inc. (0001739174) (Issuer)
• 413d
  Amendment: Chief Executive Officer Solomon Jonathan Eitan was granted 126,748 shares (SEC Form 4)

  4/A - BiomX Inc. (0001739174) (Issuer)
• 413d
  Amendment: SEC Form 4 filed by Director Goodman Jesse

  4/A - BiomX Inc. (0001739174) (Issuer)
• 413d
  Amendment: SEC Form 4 filed by Director Williams Eddie

  4/A - BiomX Inc. (0001739174) (Issuer)
• 413d
  Amendment: SEC Form 4 filed by Director Moses Alan Charles

  4/A - BiomX Inc. (0001739174) (Issuer)
• 413d
  Amendment: SEC Form 4 filed by Director Leff Jonathan S

  4/A - BiomX Inc. (0001739174) (Issuer)
• 413d
  Amendment: SEC Form 4 filed by Director Blum Susan

  4/A - BiomX Inc. (0001739174) (Issuer)
• 413d
  Amendment: SEC Form 4 filed by Director Greig Russell

  4/A - BiomX Inc. (0001739174) (Issuer)
• 413d
  Amendment: Chief Financial Officer Wolfson Marina was granted 68,545 shares (SEC Form 4)

  4/A - BiomX Inc. (0001739174) (Issuer)
• 416d
  SEC Form 4 filed by *Director by Deputization Flynn James E

  4 - BiomX Inc. (0001739174) (Issuer)
• 416d
  Chief Financial Officer Wolfson Marina was granted 68,545 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 416d
  SEC Form 4 filed by Director Leff Jonathan S

  4 - BiomX Inc. (0001739174) (Issuer)
• 416d
  SEC Form 4 filed by Director Goodman Jesse

  4 - BiomX Inc. (0001739174) (Issuer)
• 416d
  SEC Form 4 filed by Director Greig Russell

  4 - BiomX Inc. (0001739174) (Issuer)
• 416d
  Chief Development Officer Bassan Merav was granted 79,597 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 416d
  SEC Form 4 filed by Director Merril Gregory Louis

  4 - BiomX Inc. (0001739174) (Issuer)
• 416d
  Chief Executive Officer Solomon Jonathan Eitan was granted 126,748 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 416d
  SEC Form 4 filed by Director Moses Alan Charles

  4 - BiomX Inc. (0001739174) (Issuer)
• 416d
  SEC Form 4 filed by Director Blum Susan

  4 - BiomX Inc. (0001739174) (Issuer)
• 416d
  SEC Form 4 filed by Director Williams Eddie

  4 - BiomX Inc. (0001739174) (Issuer)
• 461d
  SEC Form 4 filed by Large owner Cystic Fibrosis Foundation

  4 - BiomX Inc. (0001739174) (Issuer)
• 461d
  Cystic Fibrosis Foundation increased direct ownership by 92% to 1,787,758 units (SEC Form 5)

  5 - BiomX Inc. (0001739174) (Issuer)
• 462d
  *Director by Deputization Flynn James E exercised 706,498 shares at a strike of $0.93 (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 628d
  Chief Business Officer Oron Assaf was granted 25,804 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 628d
  Chief Executive Officer Solomon Jonathan Eitan was granted 50,556 shares, increasing direct ownership by 2,022% to 53,056 units (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 628d
  Chief Development Officer Bassan Merav was granted 31,749 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 691d
  *Director by Deputization Flynn James E converted options into 11,766,000 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 693d
  SEC Form 4 filed by *Director by Deputization Flynn James E

  4 - BiomX Inc. (0001739174) (Issuer)
• 693d
  SEC Form 4 filed by Director Blum Susan

  4 - BiomX Inc. (0001739174) (Issuer)
• 693d
  SEC Form 4 filed by Director Greig Russell

  4 - BiomX Inc. (0001739174) (Issuer)
• 693d
  SEC Form 4 filed by Chief Development Officer Bassan Merav

  4 - BiomX Inc. (0001739174) (Issuer)
• 693d
  SEC Form 4 filed by Chief Financial Officer Wolfson Marina

  4 - BiomX Inc. (0001739174) (Issuer)
• 693d
  SEC Form 4 filed by Chief Executive Officer Solomon Jonathan Eitan

  4 - BiomX Inc. (0001739174) (Issuer)
• 693d
  SEC Form 4 filed by Director Leff Jonathan S

  4 - BiomX Inc. (0001739174) (Issuer)
• 693d
  SEC Form 4 filed by Director Goodman Jesse

  4 - BiomX Inc. (0001739174) (Issuer)
• 693d
  SEC Form 4 filed by Director Merril Gregory Louis

  4 - BiomX Inc. (0001739174) (Issuer)
• 693d
  SEC Form 4 filed by Director Williams Eddie

  4 - BiomX Inc. (0001739174) (Issuer)
• 693d
  SEC Form 4 filed by Chief Business Officer Oron Assaf

  4 - BiomX Inc. (0001739174) (Issuer)
• 693d
  SEC Form 4 filed by Director Moses Alan Charles

  4 - BiomX Inc. (0001739174) (Issuer)
• 697d
  SEC Form 4 filed by *Director by Deputization Flynn James E

  4 - BiomX Inc. (0001739174) (Issuer)
• 749d
  Orbimed Israel Biofund Gp Limited Partnership exercised 9,280,408 in-the-money shares at a strike of $0.24 and sold $9,280 worth of shares (24,344 units at $0.38) (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 752d
  Cystic Fibrosis Foundation exercised 4,778,265 in-the-money shares at a strike of $0.00, increasing direct ownership by 105% to 9,330,580 units (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 784d
  SEC Form 3 filed by new insider Blum Susan

  3 - BiomX Inc. (0001739174) (Issuer)
• 804d
  New insider Cystic Fibrosis Foundation claimed ownership of 4,552,315 shares (SEC Form 3)

  3 - BiomX Inc. (0001739174) (Issuer)
• 809d
  SEC Form 3 filed by new insider Leff Jonathan S

  3 - BiomX Inc. (0001739174) (Issuer)
• 809d
  SEC Form 3 filed by new insider Merril Gregory Louis

  3 - BiomX Inc. (0001739174) (Issuer)
• 809d
  SEC Form 3 filed by new insider Goodman Jesse

  3 - BiomX Inc. (0001739174) (Issuer)
• 811d
  Flynn James E was granted 6,110,098 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 811d
  SEC Form 3 filed by new insider Flynn James E

  3 - BiomX Inc. (0001739174) (Issuer)
• 811d
  SEC Form 4 filed by Orbimed Israel Biofund Gp Limited Partnership

  4 - BiomX Inc. (0001739174) (Issuer)
• 908d
  SEC Form 4 filed by Wolfson Marina

  4 - BiomX Inc. (0001739174) (Issuer)
• 908d
  SEC Form 4 filed by Bassan Merav

  4 - BiomX Inc. (0001739174) (Issuer)
• 908d
  SEC Form 4 filed by Solomon Jonathan Eitan

  4 - BiomX Inc. (0001739174) (Issuer)
• 908d
  SEC Form 4 filed by Oron Assaf

  4 - BiomX Inc. (0001739174) (Issuer)